08/17/2026
Double points on the original.
From August 17 through 28, qualifying Restylane® syringes earn 2x points with ASPIRE Galderma Rewards.†
And “original” is not a figure of speech. Restylane was the first non-animal-based HA filler approved by the FDA, back in 2003,1,2 with more than 77 million treatments worldwide since.1,2
Plan your appointment while the window is open.
†Offer terms and conditions apply.
1. Data on file. MA-57232. Galderma Laboratories, L.P., 2025.
2. FDA approval letter, dated December 12, 2003.
The most commonly observed side effects are swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. To learn more about serious but rare side effects and full Important Safety Information, visit www.RestylaneUSA.com